Drug Search Results
More Filters [+]

Enisamium iodide

Alternative Names: enisamium iodide
Latest Update: 2022-12-26
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: IAV Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Russia | Ukraine

Approved Indications: None

Known Adverse Events: None

Company: Joint Stock Company "Farmak"
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Enisamium iodide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Influenza, Human|COVID-19

Phase 2: Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

FK/FAV00А-CoV/2020

P3

Completed

COVID-19

2021-03-26

40%

2010-018564-17

P2

Terminated

Influenza, Human

2011-04-13

AM-STP-2-2008

P3

Completed

Influenza, Human

2010-01-28

26%

Recent News Events